NNVC logo

NanoViricides (NNVC) Depreciation And Amortization

Annual D&A

$759.00 K
+$11.50 K+1.54%

June 30, 2024

Summary

Performance

1-Year Change

+1.54%

3-Year Change

+7.74%

5-Year Change

+9.07%

15-Year Change

+14.48%

NNVC Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.17%
NNVC annual depreciation & amortization is higher than 34.17% of companies in Healthcare sector

High & Low

All-time High

$759.00 K
NNVC annual depreciation & amortization is currently at an all-time high

3-Year Low

$704.50 K
NNVC annual depreciation & amortization is currently +7.74% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
NNVC previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
NNVC next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$8.52 M
NNVC annual total expenses is $8.52 million

Annual Operating Expenses

$8.52 M
NNVC annual total operating expenses is $8.52 million

Annual Cost Of Goods Sold

-
NNVC annual cost of goods sold value is unknown

Annual Interest Expense

$49.80 K
NNVC annual interest expense is $49.80 thousand

Quarterly D&A

$195.90 K
+$300.00+0.15%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

NNVC Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.11%
NNVC quarterly depreciation & amortization is higher than 35.11% of companies in Healthcare sector

High & Low

All-time High

$369.90 K
NNVC quarterly depreciation & amortization is currently -47.04% below its historical high of $369.90 thousand

3-Year Low

$177.40 K
NNVC quarterly depreciation & amortization is currently +10.43% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NNVC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 15, 2025
NNVC next earnings announcement is scheduled for May 15, 2025

Related metrics

Quarterly Total Expenses

$2.06 M
NNVC quarterly total expenses is $2.06 million

Quarterly Operating Expenses

$2.06 M
NNVC quarterly total operating expenses is $2.06 million

Quarterly Cost Of Goods Sold

-
NNVC quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$100.00
NNVC quarterly interest expense is $100.00

TTM D&A

$772.10 K
+$6600.00+0.86%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

NNVC TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.73%
NNVC TTM depreciation & amortization is higher than 34.73% of companies in Healthcare sector

High & Low

All-time High

$772.10 K
NNVC TTM depreciation & amortization is currently at an all-time high

3-Year Low

$706.10 K
NNVC TTM depreciation & amortization is currently +9.35% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NNVC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 15, 2025
NNVC next earnings announcement is scheduled for May 15, 2025

Related metrics

Annual Total Expenses

$8.52 M
NNVC annual total expenses is $8.52 million

Annual Operating Expenses

$8.52 M
NNVC annual total operating expenses is $8.52 million

TTM Cost Of Goods Sold

-
NNVC TTM cost of goods sold value is unknown

TTM Interest Expense

$100.00
NNVC TTM interest expense is $100.00

NNVC Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.5%0.0%0.0%
3 y3 years+7.7%0.0%0.0%
5 y5 years+9.1%0.0%0.0%

NNVC Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.7%at high+10.4%at high+9.3%
5 y5-yearat high+9.1%at high+12.0%at high+10.6%
alltimeall timeat high+6070.7%-47.0%>+9999.0%at high>+9999.0%

NanoViricides Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
-
$195.90 K(+0.2%)
$772.10 K(+0.9%)
Sep 2024
-
$195.60 K(+2.6%)
$765.50 K(+0.9%)
Jun 2024
$759.00 K(+1.5%)
$190.60 K(+0.3%)
$759.00 K(+0.2%)
Mar 2024
-
$190.00 K(+0.4%)
$757.30 K(+0.2%)
Dec 2023
-
$189.30 K(+0.1%)
$755.60 K(+0.3%)
Sep 2023
-
$189.10 K(+0.1%)
$753.20 K(+0.8%)
Jun 2023
$747.50 K(+3.3%)
$188.90 K(+0.3%)
$747.50 K(+0.1%)
Mar 2023
-
$188.30 K(+0.7%)
$746.60 K(+0.9%)
Dec 2022
-
$186.90 K(+1.9%)
$739.90 K(+1.3%)
Sep 2022
-
$183.40 K(-2.4%)
$730.40 K(+1.0%)
Jun 2022
$723.30 K(+2.7%)
$188.00 K(+3.5%)
$723.40 K(+1.7%)
Mar 2022
-
$181.60 K(+2.4%)
$711.60 K(+0.8%)
Dec 2021
-
$177.40 K(+0.6%)
$706.10 K(+0.3%)
Sep 2021
-
$176.40 K(+0.1%)
$703.70 K(-0.1%)
Jun 2021
$704.50 K(+0.7%)
$176.20 K(+0.1%)
$704.50 K(+0.2%)
Mar 2021
-
$176.10 K(+0.6%)
$703.30 K(+0.2%)
Dec 2020
-
$175.00 K(-1.2%)
$702.10 K(+0.0%)
Sep 2020
-
$177.20 K(+1.3%)
$702.00 K(+0.3%)
Jun 2020
$699.70 K(+0.5%)
$175.00 K(+0.1%)
$699.70 K(+0.1%)
Mar 2020
-
$174.90 K(0.0%)
$699.10 K(+0.1%)
Dec 2019
-
$174.90 K(0.0%)
$698.40 K(+0.1%)
Sep 2019
-
$174.90 K(+0.3%)
$697.40 K(+0.2%)
Jun 2019
$695.90 K(+2.3%)
$174.40 K(+0.1%)
$695.90 K(+0.3%)
Mar 2019
-
$174.20 K(+0.2%)
$694.00 K(+0.5%)
Dec 2018
-
$173.90 K(+0.3%)
$690.30 K(+0.7%)
Sep 2018
-
$173.40 K(+0.5%)
$685.20 K(+0.7%)
Jun 2018
$680.10 K(+2.6%)
$172.50 K(+1.2%)
$680.10 K(+0.8%)
Mar 2018
-
$170.50 K(+1.0%)
$675.00 K(+0.7%)
Dec 2017
-
$168.80 K(+0.3%)
$670.20 K(+0.6%)
Sep 2017
-
$168.30 K(+0.5%)
$665.90 K(+0.4%)
Jun 2017
$663.00 K(+0.5%)
$167.40 K(+1.0%)
$663.00 K(+0.5%)
Mar 2017
-
$165.70 K(+0.7%)
$659.90 K(+0.0%)
Dec 2016
-
$164.50 K(-0.5%)
$659.80 K(-0.2%)
Sep 2016
-
$165.40 K(+0.7%)
$661.20 K(+0.3%)
Jun 2016
$659.50 K
$164.30 K(-0.8%)
$659.50 K(+3.5%)
Mar 2016
-
$165.60 K(-0.2%)
$637.50 K(+21.4%)
Dec 2015
-
$165.90 K(+1.3%)
$525.30 K(+27.2%)
DateAnnualQuarterlyTTM
Sep 2015
-
$163.70 K(+15.0%)
$412.90 K(+36.4%)
Jun 2015
$302.70 K(+42.8%)
$142.30 K(+166.5%)
$302.70 K(+41.5%)
Mar 2015
-
$53.40 K(-0.2%)
$213.90 K(+2.6%)
Dec 2014
-
$53.50 K(0.0%)
$208.50 K(-1.0%)
Sep 2014
-
$53.50 K(0.0%)
$210.50 K(-0.7%)
Jun 2014
$212.00 K(-3.5%)
$53.50 K(+11.5%)
$211.90 K(-0.7%)
Mar 2014
-
$48.00 K(-13.5%)
$213.30 K(-3.1%)
Dec 2013
-
$55.50 K(+1.1%)
$220.20 K(+0.3%)
Sep 2013
-
$54.90 K(0.0%)
$219.60 K(0.0%)
Jun 2013
$219.70 K(0.0%)
$54.90 K(0.0%)
$219.60 K(0.0%)
Mar 2013
-
$54.90 K(0.0%)
$219.60 K(0.0%)
Dec 2012
-
$54.90 K(0.0%)
$219.60 K(0.0%)
Sep 2012
-
$54.90 K(0.0%)
$219.60 K(0.0%)
Jun 2012
$219.70 K(-58.4%)
$54.90 K(0.0%)
$219.60 K(-58.9%)
Mar 2012
-
$54.90 K(0.0%)
$534.60 K(+0.4%)
Dec 2011
-
$54.90 K(0.0%)
$532.50 K(+0.2%)
Sep 2011
-
$54.90 K(-85.2%)
$531.50 K(+0.7%)
Jun 2011
$527.70 K(+484.4%)
$369.90 K(+600.6%)
$527.70 K(+157.7%)
Mar 2011
-
$52.80 K(-2.0%)
$204.80 K(+9.2%)
Dec 2010
-
$53.90 K(+5.5%)
$187.50 K(+36.4%)
Sep 2010
-
$51.10 K(+8.7%)
$137.50 K(+52.3%)
Jun 2010
$90.30 K(+634.1%)
$47.00 K(+32.4%)
$90.30 K(+90.1%)
Mar 2010
-
$35.50 K(+810.3%)
$47.50 K(+206.5%)
Dec 2009
-
$3900.00(0.0%)
$15.50 K(+6.2%)
Sep 2009
-
$3900.00(-7.1%)
$14.60 K(+18.7%)
Jun 2009
$12.30 K(-8.9%)
$4200.00(+20.0%)
$12.30 K(-26.8%)
Mar 2009
-
$3500.00(+16.7%)
$16.80 K(+9.8%)
Dec 2008
-
$3000.00(+87.5%)
$15.30 K(+10.9%)
Sep 2008
-
$1600.00(-81.6%)
$13.80 K(+2.2%)
Jun 2008
$13.50 K(-62.8%)
$8700.00(+335.0%)
$13.50 K(-58.8%)
Mar 2008
-
$2000.00(+33.3%)
$32.80 K(+4.1%)
Dec 2007
-
$1500.00(+15.4%)
$31.50 K(+2.3%)
Sep 2007
-
$1300.00(-95.4%)
$30.80 K(-15.2%)
Jun 2007
$36.30 K(-72.5%)
$28.00 K(+3900.0%)
$36.30 K(+337.3%)
Mar 2007
-
$700.00(-12.5%)
$8300.00(+9.2%)
Dec 2006
-
$800.00(-88.2%)
$7600.00(+11.8%)
Sep 2006
-
$6800.00
$6800.00
Jun 2006
$131.90 K
-
-

FAQ

  • What is NanoViricides annual depreciation & amortization?
  • What is the all time high annual D&A for NanoViricides?
  • What is NanoViricides annual D&A year-on-year change?
  • What is NanoViricides quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for NanoViricides?
  • What is NanoViricides quarterly D&A year-on-year change?
  • What is NanoViricides TTM depreciation & amortization?
  • What is the all time high TTM D&A for NanoViricides?
  • What is NanoViricides TTM D&A year-on-year change?

What is NanoViricides annual depreciation & amortization?

The current annual D&A of NNVC is $759.00 K

What is the all time high annual D&A for NanoViricides?

NanoViricides all-time high annual depreciation & amortization is $759.00 K

What is NanoViricides annual D&A year-on-year change?

Over the past year, NNVC annual depreciation & amortization has changed by +$11.50 K (+1.54%)

What is NanoViricides quarterly depreciation & amortization?

The current quarterly D&A of NNVC is $195.90 K

What is the all time high quarterly D&A for NanoViricides?

NanoViricides all-time high quarterly depreciation & amortization is $369.90 K

What is NanoViricides quarterly D&A year-on-year change?

Over the past year, NNVC quarterly depreciation & amortization has changed by $0.00 (0.00%)

What is NanoViricides TTM depreciation & amortization?

The current TTM D&A of NNVC is $772.10 K

What is the all time high TTM D&A for NanoViricides?

NanoViricides all-time high TTM depreciation & amortization is $772.10 K

What is NanoViricides TTM D&A year-on-year change?

Over the past year, NNVC TTM depreciation & amortization has changed by $0.00 (0.00%)